Article
Defining the molecular pathology of pancreatic body and tail adenocarcinoma.
The British journal of surgery - 1 Jan 2018
Dreyer S B, Jamieson N B, Upstill-Goddard R, Bailey P J, McKay C J, Biankin A V, Chang D K
Abstract excerpt
BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) remains a dismal disease, with very little improvement in survival over the past 50 years. Recent large-scale genomic studies have improved understanding of the genomic and transcriptomic landscape of the disease, yet very little is known about molecular heterogeneity according to tumour location in the pancreas; body and tail PDACs especially tend to have a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
